The threat of multidrug resistance: is tuberculosis ever untreatable or uncontrollable?

With multiple-resistant tuberculosis accounting for between 0 and 54% of tuberculosis cases around the world, the threat it poses cannot be underestimated.

Saved in:
Bibliographic Details
Published in:The Lancet (British edition) 1999-03, Vol.353 (9157), p.998-999
Main Author: Gleissberg, Virginia
Format: Article
Language:English
Subjects:
Antibiotics, Antitubercular - therapeutic use
Antitubercular Agents - therapeutic use
Drug resistance
Drug therapy
Humans
Isoniazid - therapeutic use
Patient Compliance
Rifampin - therapeutic use
Treatment Outcome
Tuberculosis
Tuberculosis, Multidrug-Resistant - drug therapy
Tuberculosis, Multidrug-Resistant - economics
Tuberculosis, Multidrug-Resistant - prevention & control
Tuberculosis, Pulmonary - drug therapy
Tuberculosis, Pulmonary - economics
Tuberculosis, Pulmonary - prevention & control
United Kingdom
United States
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:With multiple-resistant tuberculosis accounting for between 0 and 54% of tuberculosis cases around the world, the threat it poses cannot be underestimated.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(99)01439-7